Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Innovation in Action: Leveraging KOLs and AI for Unrivaled Brand Advocacy

October 14, 2025

HCPs trust their peers more than anyone, but they're also busier than ever. Learn how to leverage the credibility of KOLs and the power of AI to deliver vital information.

Two female Healthcare Professionals (HCPs) in lab coats reviewing glowing digital data and medical information on a screen, demonstrating a modern, high-tech approach to community and collaboration

Building a Better Bridge: Why a Dedicated Community is the Future of HCP Engagement

October 7, 2025

In the battle for HCP attention, the loudest voice doesn't win—the most trusted one does.

The Missing Link: Marrying Clinical Data with Patient Insights

September 30, 2025

Discover how connecting hard data with human experience is the key to unlocking richer provider-patient conversations and stronger brand advocacy.

A Catalyst for Connection: How a Crackdown on DTC Ads Could Transform Pharma Ads to Better Serve Patients

September 24, 2025

The future of health advertising belongs to thoughtful, digitally-driven, opted-in media and specialized content that prioritizes patient education and advocacy above all else.

People with COPD want more from their doctors: Here’s what they say

August 14, 2018

Debilitating. Frustrating. Devastating. When asked to describe their condition in one word, COPD patients’ choice of words reveals struggle, fear, misery, and helplessness in Health Union’s COPD In America 2018 survey.

Differences in DMT treatment experiences among people with MS: Here’s what patients say

July 30, 2018

For many people living with multiple sclerosis (MS), treatment decisions can often be nuanced and complicated. In April of 2018, the American Academy of Neurology (AAN) released new guidelines about when to begin, change, and end disease-modifying therapies (DMTs) for MS patients. MS In America 2018 results may help the healthcare industry gain a broader understanding of people’s experiences, or lack thereof, with DMTs and other MS treatment options.

WHITEPAPER DOWNLOAD: #authenticity How Social Media Can Fuel Growth-Oriented, Sustainable Online Communities

June 28, 2018

Download the full free whitepaper, “#authenticity How Social Media Can Fuel Growth-Oriented, Sustainable Online Communities”

Expanding Patient Voices and Understanding Their Perspectives

Patient Centricity Starts With Patients: Closing the Trial Recruitment Gap

June 27, 2018

There is a lot of talk in the industry about patient centricity, but is it the reality? We talk about putting the needs of patients first and keeping them central in the business decisions we make across the healthcare industry. However, as we discussed on a panel at this year’s DIA 2018 Global Annual Meeting, somehow in the effort to amplify patient centricity, a critical voice is often underrepresented—the voice of the patient.

Healthcare Industry Thought Leadership

Contact